Proactive Investors - Run By Investors For Investors

Euromoney agrees to buy BoardEx and The Deal for US$87.3mln

BoardEx is an executive profiling and relationship mapping platform, while The Deal is a trusted source of data, news and intelligence on mergers and acquisitions, activist investing, private equity and restructuring
Euromoney agrees to buy BoardEx and The Deal for US$87.3mln
Euromoney said the two platforms were perfectly placed to grow further under its ownership

Euromoney Institutional Investor PLC (LON:ERM) has agreed to acquire BoardEx and The Deal, from parent company TheStreet, for US$87.3mln.

BoardEx is an executive profiling and relationship mapping platform, while The Deal is a trusted source of data, news and intelligence on mergers and acquisitions, activist investing, private equity and restructuring.

READ: Euromoney's profit rise, re-jigs research arm

Euromoney said the combined products had a consistent track record of growth in revenue and earnings over recent years which it expects to continue. In the year to 30 September 2018, The Deal’s unaudited revenue was US$25.2mln.

Approval by TheStreet’s shareholders is expected to take place during the first quarter of 2019, Euromoney said.

“I am excited by the acquisition of BoardEx and The Deal, which brings two additional high-quality assets into Euromoney's portfolio and supports our transition towards a next generation 3.0 business model,' Euromoney’s CEO Andrew Rashbass said in a statement.

“The businesses are perfectly placed to grow further under Euromoney ownership, with the group's existing data expected to enhance the BoardEx platform. We look forward to working with the management team and our new colleagues around the world to develop these leading brands and take advantage of the compelling growth opportunities they offer.”

View full ERM profile View Profile

Euromoney Institutional Investor Timeline

Related Articles

clapperboard
December 19 2018
Interim profits showed a modest recovery with the number of contracts signed rising to 77 from 74 a year earlier
mobile marketing
February 01 2019
The merger is structured as an offer by Taptica that will see it owning 50.1% of the enlarged group and Rhythm One owning the remaining 49.9%
ipad
September 19 2018
“Cello Health is successfully building its early stage asset development advisory platform for biotech clients, as well as growing its core later stage and post-launch franchise with pharmaceutical clients”

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use